三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LABU 三倍做多标普生物-Direxion

休市中 05-22 16:00:00 EDT

175.19

-4.44

-2.47%

盘后174.02

-1.17-0.67%

19:59 EDT

最高185.29	最低174.08	成交量39.98万
今开179.63	昨收179.63	日振幅6.24%
总市值5.47亿	流通市值5.47亿	总股本312.45万
成交额7,152万	换手率12.79%	流通股本312.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":175.19,"timestamp":1779480000000,"preClose":179.63,"halted":0,"volume":399769,"hourTrading":{"tag":"盘后","latestPrice":174.02,"preClose":175.19,"latestTime":"19:59 EDT","volume":4530,"amount":790902.3842,"timestamp":1779494369772,"change":-1.17,"changeRate":-0.006678,"amplitude":0.010845},"delay":0,"changeRate":-0.02471747480933028,"floatShares":3124486,"shares":3124486,"eps":0,"marketStatus":"休市中","change":-4.44,"latestTime":"05-22 16:00:00 EDT","open":179.63,"high":185.29,"low":174.08,"amount":71523711.1894,"amplitude":0.062406,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":179.63,"sharesOutstanding":3024486,"nav":179.532,"aum":551968484.04,"dividendRate":0.007004,"bidAskSpread":0.002681,"preHourTrading":{"tag":"盘前","latestPrice":179.61,"preClose":179.63,"latestTime":"09:28 EDT","volume":1398,"amount":252178.88706,"timestamp":1779456485406,"change":-0.02,"changeRate":-0.000111,"amplitude":0.029335},"postHourTrading":{"tag":"盘后","latestPrice":174.02,"preClose":175.19,"latestTime":"19:59 EDT","volume":4530,"amount":790902.3842,"timestamp":1779494369772,"change":-1.17,"changeRate":-0.006678,"amplitude":0.010845},"volumeRatio":0.644943,"impliedVol":0.7891,"impliedVolPercentile":0.1275},"requestUrl":"/m/hq/s/LABU","defaultTab":"news","newsList":[{"id":"1134250665","title":"医疗健康板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1134250665","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134250665?lang=zh_cn&edition=full","pubTime":"2026-05-23 04:53","pubTimestamp":1779483220,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康板块的市场对话。0955 ET - 美国临床肿瘤学会发布了一项研究的摘要，摩根大通称之为对默克公司与中国生物科技公司科伦博泰生物制药联合开发的靶向化疗药物sac-TMT疗法“高度令人鼓舞”。默克股价上涨4%。Recordati股价下跌0.3%，而CVC和GBL股价均上涨1%。ING表示，此次要约也表明GBL对医疗健康领域抱有浓厚兴趣，该集团已涉足服务和医疗技术领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","BK4585","LABU","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334265","title":"商业健康险冲规模 如何向团体险业务“要增长”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334265","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637334265?lang=zh_cn&edition=full","pubTime":"2026-05-23 02:37","pubTimestamp":1779475035,"startTime":"0","endTime":"0","summary":"商业健康险市场整体增长乏力的背景下，团体业务是否有望成为增长突破口？《中国经营报》记者注意到，今年以来，多家机构在加码布局团体健康险业务。近期，太平人寿的业务范围中获批增加“团体长期健康保险”。定位医疗科技和健康管理的思派健康（00314.HK）在近期披露的2025年年报中提到：“进一步明确并深化以企业健康保险经纪业务为核心的发展战略。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605233747103797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1247","LABU","XLV","BK4581","BK4585","00314","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189495240","title":"医疗保健板块市场动态聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1189495240","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189495240?lang=zh_cn&edition=full","pubTime":"2026-05-22 00:26","pubTimestamp":1779380815,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场动态。这家医疗器械公司表示，截至目前的有机营收增长为4.8%，并重申了全年业绩指引。公司称，由于客户订单分阶段执行以及新产品发布，下半年增长将加速。目前股价下跌6.5%，至200.20便士。**Forsyth Barr聚焦养老社区运营商Ryman Healthcare财报要点**：Forsyth Barr指出了养老社区运营商Ryman Healthcare将于周二发布的2026财年业绩中的三个关注重点。其次，该机构期待Ryman在削减业务成本方面取得进展。Forsyth Barr维持对Ryman的“跑赢大盘”评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","XLV","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637324783","title":"Adagio Medical向FDA提交vCLAS®心室消融系统上市前批准申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2637324783","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637324783?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:39","pubTimestamp":1779374340,"startTime":"0","endTime":"0","summary":"医疗器械生产商Adagio Medical Holdings， Inc．宣布，已向美国食品药品监督管理局提交了vCLAS心室消融系统的上市前批准申请。该系统用于治疗药物难治性、复发性、持续性单形性室性心动过速患者，这些患者伴有缺血性或非缺血性结构性心脏病。　　Adagio Medical首席执行官Todd Usen表示，此次PMA申请提交对公司和众多室性心动过速患者而言都是一个决定性时刻，目前这些患者尚无专门的治疗解决方案。　　Adagio的vCLAS系统已在欧洲获得CE标志并上市，在美国仅限于研究用途。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-21/doc-inhysnxc6296050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637342543","title":"拜耳(BAYRY)新药获FDA优先审评 肾科用药版图扩容","url":"https://stock-news.laohu8.com/highlight/detail?id=2637342543","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637342543?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:10","pubTimestamp":1779372601,"startTime":"0","endTime":"0","summary":"金吾财讯 | 拜耳 宣布，其肾病治疗药物 Kerendia的补充新药申请获美国 FDA 受理并授予优先审查资格，用于治疗 1 型糖尿病相关慢性肾病成年患者。结果显示，非奈利酮可显著降低患者尿白蛋白与肌酐比值，这一指标是评估 1 型糖尿病合并慢性肾病患者肾脏事件的核心预测因子Bayer。若本次新适应症顺利获批，Kerendia 将成为首款针对 1 型糖尿病相关慢性肾病的盐皮质激素受体拮抗剂，填补临床治疗空白。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300702","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4585","LABU","BAYRY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637938136","title":"圣诺生物(688117.SH)：醋酸特利加压素原料药完成美国FDA备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2637938136","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637938136?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:41","pubTimestamp":1779356503,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣诺生物(688117.SH)发布公告，公司全资子公司成都圣诺生物制药有限公司的醋酸特利加压素原料药于近日通过美国食品药品监督管理局(FDA)的DMF备案，目前处于激活状态，可被制剂生产企业引用申报。本次醋酸特利加压素原料药完成美国食品药品监督管理局(FDA)DMF备案，有利于公司推进在国际市场的药品销售，提升公司产品的国际影响力，有望对公司长期经营业绩产生积极影响。由于医药产品的行业特点，上述药品的具体销售情况可能受到国家政策、市场环境变化等因素影响，具有较大不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0239","688117","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637383629","title":"普洛药业(000739.SZ)：琥珀酸美托洛尔缓释片新增25mg规格获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2637383629","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637383629?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:18","pubTimestamp":1779351483,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 普洛药业 发布公告，近日，公司之全资子公司浙江巨泰药业有限公司收到美国食品药品监督管理局签发的琥珀酸美托洛尔缓释片新增25mg规格PAS的批准通知。琥珀酸美托洛尔缓释片为治疗高血压、心绞痛、伴有左心室收缩功能异常的症状稳定的慢性心力衰竭等适应症的药物。此次琥珀酸美托洛尔缓释片新增获批25mg规格，可为该品种的市场推广提供更多选择，有利于进一步扩大国外市场，对公司经营发展具有一定的积极作用。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4588","BK0239","BK4585","BK0188","BK0060","LABU","000739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636882570","title":"刘强东联手宿迁国资等成立10亿元投资基金 聚焦前沿科技、泛消费以及医疗健康领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2636882570","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636882570?lang=zh_cn&edition=full","pubTime":"2026-05-20 22:42","pubTimestamp":1779288120,"startTime":"0","endTime":"0","summary":"其中，宿迁辉远投资管理有限公司认缴出资2亿元；宿迁天智时代企业管理有限公司认缴出资9000万元；宿迁知周企业管理有限公司认缴出资1000万元。图片来源：洋河股份公告洋河股份此前公告称，该基金目标总额不超过13亿元，投资方向为前沿科技、泛消费、医疗健康等领域的项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-05-20/doc-inhyqiyc6777211.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-05-20/doc-inhyqiyc6777211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0345775950.USD","LU1188198961.HKD","LABU","LU0488056044.USD","LU0588545490.SGD","LU0672654166.SGD","IE00B3M56506.USD","LU1770034418.SGD","LU0828237510.HKD","BK4585","LU0163747925.USD","SGXZ62798434.SGD","LU1282649810.SGD","BK1591","LU0499858438.USD","LU0084288322.USD","BK4509","LU0871576103.HKD","09618","LU2257852520.SGD","LU0228659784.USD","LU0588546209.SGD","LU1481107354.HKD","LU1719994722.HKD","LU0164865239.USD","LU1251922891.USD","BK4531","JD","BK4579","LU0327786744.USD","LU0499858602.USD","SG9999002562.SGD","LU1813983027.USD","LU1023057109.AUD","LU0315179316.USD","LU0348825331.USD","BK1615","LU0572944931.SGD","LU0293314216.USD","BK4581","LU0543330483.HKD","SGXZ86797644.SGD","86618","BK4524","HK0000306701.USD","LU0211977185.USD","LU0594300419.USD","LU0320764599.SGD","LU0315178854.USD","LU1303224171.USD","LU1282649067.USD","LU1366334651.USD","LU2242644610.SGD","LU0314109678.HKD","BK1247","LU0650527681.SGD","LU0039217434.USD","89618","BK1515","LU0456842615.SGD","LU0868486357.SGD","IE00BGV7N243.SGD","LU0106959298.USD","LU1282651121.HKD","BK4122","HK0000320223.HKD","LU0348805143.USD","LU1808992512.USD","IE0032431581.USD","LU1044875133.USD","SG9999002463.SGD","LU0326950275.SGD","LU0370786039.SGD","LU1642822792.SGD","BK4551","BK4550","BK4505","BK1583","LU0588545904.SGD","LU1044876610.USD","LU0708995583.HKD","BK1142","LU0359201612.USD","BK1249","LU0164880469.USD","LU0359201885.HKD","LU1770036033.HKD","LU0228367735.SGD","BK4220","BK4503","LU0456827905.SGD","BK1588","LU1224444064.USD","LU0791591158.USD","LU0865486749.SGD","BK1610","LU0431992006.USD","LU1794554557.SGD","HK0000320264.USD","LU1720050803.USD","XBI","LU0320764755.SGD","LU0463099449.HKD","LU0359202008.SGD","LU0051755006.USD","LU0531971595.HKD","LU0029875118.USD","LU0048580855.USD","BK1502","LU0348735423.USD","LU1282651048.USD","IE00B29SXG58.USD","LU0791590937.USD","BK4614","BK1571","LU1880383366.USD","BK4526","LU1328277881.USD","IE0008368742.USD","SG9999001226.SGD","BK1619","LU0456846285.SGD","LU1044874839.SGD","LU1366334578.USD","LU0588545730.USD","LU1688375341.USD","LU0345776255.USD","LU2039709279.SGD","BK1575","LU0469268626.HKD","LU0231483743.USD","LU0052750758.USD","BK4504","LU0244354667.USD","SG9999002828.SGD","LU0128522157.USD","LU0140636845.USD","LU0384037296.USD","KJD","LU0259732245.USD","LU0307460666.USD","LU0417516738.SGD","BK4588","BK1589","BK4558","LU0417516902.SGD","HK0000306685.HKD","LU0149721374.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636847240","title":"Scholar Rock将出席杰富瑞全球医疗保健大会，聚焦SMA新药apitegromab关键审批","url":"https://stock-news.laohu8.com/highlight/detail?id=2636847240","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636847240?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:55","pubTimestamp":1779281725,"startTime":"0","endTime":"0","summary":"Scholar Rock公司宣布，管理层将于2026年6月3日上午11：40在纽约出席杰富瑞全球医疗保健大会并进行炉边谈话。此次活动正值公司核心药物apitegromab处于FDA审批的关键窗口期，备受投资者关注。　　根据公司公告，Scholar Rock董事长兼首席执行官David Hallal将代表公司出席此次大会。　　Scholar Rock的核心资产apitegromab是一种首创的肌肉靶向单克隆抗体，用于治疗脊髓性肌萎缩症。　　Scholar Rock正在将apitegromab的开发拓展至2岁以下婴幼儿SMA患者，其名为OPAL的2期试验正在持续入组和给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-20/doc-inhyqcsh9578240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4127","BK4217","XBI","BK4550","JEF","BK4559","SMA","VHT","XLV","BK4588","LABU","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636145813","title":"港股异动 | 百济神州(06160)涨近3% 近日索托克拉美国FDA获批 公司首季度净利超出市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2636145813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636145813?lang=zh_cn&edition=full","pubTime":"2026-05-20 13:58","pubTimestamp":1779256684,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州涨近3%，截至发稿，涨2.23%，报178.7港元，成交额4.67亿港元。此前，百济神州披露26Q1业绩，中金指出，收入15.13亿美元，同比增长35%，其中产品收入14.87亿美元，同比增长34%，GAAP净利润2.27亿美元，同比增加2.26亿美元，销售收入符合该行预期，净利润超该行预期，主因费用控制较好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","ONC","BK1583","LU2328871848.SGD","BK4139","BK4588","688235","BK1161","BK4526","LU1969619763.USD","LU0307460666.USD","06160","LABU","LU1770034418.SGD","LU0588546209.SGD","LU1303224171.USD","LU1251922891.USD","BK1500","BK0239","BK4585","BK1588","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636836985","title":"拜耳(BAYRY)新药获FDA优先审评 聚焦二次中风预防","url":"https://stock-news.laohu8.com/highlight/detail?id=2636836985","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636836985?lang=zh_cn&edition=full","pubTime":"2026-05-19 16:10","pubTimestamp":1779178215,"startTime":"0","endTime":"0","summary":"值得注意的是，asundexian 在 2023 年已获得 FDA 快速通道资格，此次优先审评资格的授予，进一步凸显了该药物在二次中风预防领域的潜在价值。FDA 的优先审评资格，主要授予那些获批后能显著提升严重疾病治疗、预防或诊断安全性与有效性的药物。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300574","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BAYRY","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636888668","title":"两部门：聚焦重点违规行为 加强定点零售药店职工医保个人账户使用监管","url":"https://stock-news.laohu8.com/highlight/detail?id=2636888668","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636888668?lang=zh_cn&edition=full","pubTime":"2026-05-19 08:51","pubTimestamp":1779151860,"startTime":"0","endTime":"0","summary":"三、加强定点零售药店协议管理各地要及时将定点零售药店职工医保个人账户支付白名单及有关要求作为定点零售药店协议管理事项，制定补充协议或修订协议文本，及时与定点零售药店签订协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","BK4581","BK4588","BK4585","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636888589","title":"我国建立白名单制度规范医保个人账户使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2636888589","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636888589?lang=zh_cn&edition=full","pubTime":"2026-05-19 08:45","pubTimestamp":1779151548,"startTime":"0","endTime":"0","summary":"允许使用职工医保个人账户支付在定点医疗机构发生的流感疫苗费用","market":"hk","thumbnail":"https://img3.gelonghui.com/be61d-1627d25f-2f53-4432-94b9-473c474a2808.jpg?guru_height=820&guru_width=1280&guru_size=164866","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/be61d-1627d25f-2f53-4432-94b9-473c474a2808.jpg?guru_height=820&guru_width=1280&guru_size=164866"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4814060","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["XLV","BK4581","BK4588","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636700080","title":"广药接手达安基因；阿斯利康高血压创新药获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2636700080","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636700080?lang=zh_cn&edition=full","pubTime":"2026-05-19 08:01","pubTimestamp":1779148914,"startTime":"0","endTime":"0","summary":"政策动向2026年医保目录调整新增预申报允许商保创新药申报医保目录国家医保局介绍2026年国家医保药品目录及商业健康保险创新药品目录调整工作安排，包括首次允许纳入2025年商保创新药目录的药品申报国家医保目录，新增“预申报”环节等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605193741160824.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605193741160824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2417539215.USD","LU2236285917.USD","BK1161","LU0058720904.USD","LU2237443549.SGD","159992","BK0028","BK0122","LU2237443382.USD","LU2237443895.HKD","BK0168","LU2462157665.USD","BK0239","LU0109394709.USD","LU1829250122.USD","LU2237443978.SGD","BK0046","06978","BK0159","LABU","LU2456880835.USD","002030","LU2237443622.USD","BK4568","BK4588","LU2237443465.HKD","LU0889565916.HKD","BK0042","LU0320765992.SGD","BK1574","BK0188","AZNH","BK4007","BK4585","LU0289739699.SGD","AZN","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636079891","title":"特朗普一纸行政令引爆迷幻药赛道：有公司火速融资500万美元，机构资金开始“电话轰炸”","url":"https://stock-news.laohu8.com/highlight/detail?id=2636079891","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636079891?lang=zh_cn&edition=full","pubTime":"2026-05-18 21:12","pubTimestamp":1779109941,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国总统特朗普签署的加速迷幻药研发行政令，正在激发相关药企对吸引更多资本的期待。多家公司表示，新增资金目前仍只是期望。但迷幻药开发商Enveric Biosciences CEO约瑟夫·塔克透露，特朗普行政令消息传出后，公司已成功融资500万美元。“一旦行政令层面有动作，电话就会响个不停。”DEA对药物进行分级，决定其管控严格程度及是否可处方。PsyMed的塞雷布林斯基指出，行政令可能加快审评速度，但未明确迷幻药疗法的医保报销障碍。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443125.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4194","BK4223","DEA","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636024622","title":"百奥泰(688177.SH)：BAT2506获美国FDA上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2636024622","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636024622?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:58","pubTimestamp":1779098337,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥泰 发布公告，公司于近日收到美国食品药品监督管理局签发的关于Immgolis/Immgolis Intri上市批准通知。据悉，BAT2506是百奥泰根据中国国家药品监督管理局、FDA、欧洲药品管理局生物类似药相关指导原则开发的戈利木单抗生物类似药。截至本公告披露日，BAT2506已获得FDA、EMA上市批准，美国商品名为Immgolis/Immgolis Intri，欧洲注册商品名为Gotenfia;已向NMPA、巴西国家卫生监督局等递交上市许可申请，目前正在评审中。BAT2506的商业化授权合作目前已覆盖118个国家和地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","BK0239","BK4588","IPOS","BK4585","688177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635523490","title":"计划三年100万人次！浙江为新就业形态劳动者送上“双重医靠”","url":"https://stock-news.laohu8.com/highlight/detail?id=2635523490","media":"浙江发布","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635523490?lang=zh_cn&edition=full","pubTime":"2026-05-16 12:21","pubTimestamp":1778905260,"startTime":"0","endTime":"0","summary":"《实施方案》提出目标任务对首次参加浙江省城镇职工基本医疗保险且加入工会的新就业形态劳动者，全额赠送职工医疗互助保障；对持续参加浙江省城镇职工基本医疗保险且加入工会的新就业形态劳动者，参加职工医疗互助保障时给予不低于50%的保费补助；当地职工医疗互助保障允许适用于参加浙江省城乡居民基本医疗保险参保对象的，执行上述参保赠送（补助）政策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-16/doc-inhyahat4641919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","BK4585","XLV","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635032300","title":"美国FDA再失核心高管，药品审评研究中心主任Hoeg即将离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2635032300","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635032300?lang=zh_cn&edition=full","pubTime":"2026-05-16 03:28","pubTimestamp":1778873280,"startTime":"0","endTime":"0","summary":"　　美国食品药品监督管理局的领导层动荡仍在持续。继前任局长马蒂·马卡里本周二辞职后，药品审评与研究中心代理主任特蕾西·贝丝·霍格预计也将离职。　　这一消息由多位知情人士透露，目前HHS发言人已表示不对人事问题置评，相关决定尚未最终敲定。她是前局长马卡里的坚定盟友，因对新冠疫情期间的疫苗政策持怀疑态度而闻名。此前，生物制品审评与研究中心主任维奈·普拉萨德也已离职。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-16/doc-inhxzkwy6164576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635006034","title":"基因泰克Tecentriq获FDA批准，用于ctDNA阳性膀胱癌辅助治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2635006034","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635006034?lang=zh_cn&edition=full","pubTime":"2026-05-16 03:15","pubTimestamp":1778872500,"startTime":"0","endTime":"0","summary":"　　5月15日，罗氏旗下基因泰克公司宣布，美国食品药品监督管理局已批准其免疫疗法Tecentriq及皮下注射剂Tecentriq Hybreza，用于根治性膀胱切除术后、经FDA授权检测确认存在循环肿瘤DNA分子残留病变的肌层浸润性膀胱癌成人患者的辅助治疗。中位总生存期同样显著改善，Tecentriq组为32.8个月，安慰剂组为21.1个月，死亡风险降低41%。　　这是Tecentriq在美国获得的第11个适应症批准。该药物还被批准用于治疗非小细胞肺癌、三阴性乳腺癌和肝细胞癌等多种癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-16/doc-inhxzkwy6160888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635034746","title":"FDA全面叫停Aardvark PWS新药临床试验，股价应声暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2635034746","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635034746?lang=zh_cn&edition=full","pubTime":"2026-05-16 03:04","pubTimestamp":1778871840,"startTime":"0","endTime":"0","summary":"　　美国食品药品监督管理局已对Aardvark Therapeutics的核心在研药物ARD-101发布全面临床搁置命令，冻结所有针对普拉德-威利综合征的现有临床试验。受此消息冲击，该公司股价在周五盘前交易中一度暴跌超30%，收盘跌幅约24%，年初至今累计跌幅已超过60%。Aardvark早于今年2月便主动暂停了相关研究，但FDA的最新决定使该项目前景更加黯淡。为寻求出路，Aardvark计划对已积累的III期临床数据进行揭盲分析，以评估ARD-101的整体安全性与有效性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-16/doc-inhxzkwx3102453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","PWS","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":-0.1418},{"period":"3month","weight":0.0735},{"period":"6month","weight":0.2304},{"period":"1year","weight":2.4446},{"period":"ytd","weight":0.0991}],"compareEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.0815},{"period":"6month","weight":0.1314},{"period":"1year","weight":0.2788},{"period":"ytd","weight":0.0934}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.020883},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.009536},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.135885},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.001739},{"month":5,"riseRate":0.545455,"avgChangeRate":0.005793},{"month":6,"riseRate":0.727273,"avgChangeRate":0.127955},{"month":7,"riseRate":0.636364,"avgChangeRate":0.054287},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.004065},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.0652},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.047038},{"month":11,"riseRate":0.818182,"avgChangeRate":0.199161},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.032237}],"exchange":"ARCA","name":"三倍做多标普生物-Direxion","nameEN":"Direxion Daily S&P Biotech Bull 3x Shares"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三倍做多标普生物-Direxion,LABU,三倍做多标普生物-Direxion股票,三倍做多标普生物-Direxion股票老虎,三倍做多标普生物-Direxion股票老虎国际,三倍做多标普生物-Direxion行情,三倍做多标普生物-Direxion股票行情,三倍做多标普生物-Direxion股价,三倍做多标普生物-Direxion股市,三倍做多标普生物-Direxion股票价格,三倍做多标普生物-Direxion股票交易,三倍做多标普生物-Direxion股票购买,三倍做多标普生物-Direxion股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三倍做多标普生物-Direxion(LABU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三倍做多标普生物-Direxion(LABU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}